{"id":"https://openalex.org/W4362493073","doi":"https://doi.org/10.1158/1535-7163.c.6536475","title":"Data from ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models","display_name":"Data from ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362493073","doi":"https://doi.org/10.1158/1535-7163.c.6536475"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6536475","doi":"https://doi.org/10.1158/1535-7163.c.6536475","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536475","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.6536475","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100425554","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0002-3617-2627","observed_orcids":["https://orcid.org/0000-0002-3617-2627","https://orcid.org/0000-0003-2756-2620","https://orcid.org/0009-0001-8129-4308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078906917","display_name":"Carla Castanaro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carla Castanaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Bo Luan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bo Luan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048903143","display_name":"Katie Yang","orcid":"https://orcid.org/0000-0002-7587-9350","observed_orcids":["https://orcid.org/0000-0002-7587-9350"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katie Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058237813","display_name":"Liangfen Fan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liangfen Fan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049321550","display_name":"Jeanette L. Fairhurst","orcid":"https://orcid.org/0000-0003-2442-5348","observed_orcids":["https://orcid.org/0000-0003-2442-5348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeanette L. Fairhurst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003106049","display_name":"Ashique Rafique","orcid":"https://orcid.org/0000-0003-4078-7242","observed_orcids":["https://orcid.org/0000-0003-4078-7242"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashique Rafique","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004345979","display_name":"Terra B. Potocky","orcid":"https://orcid.org/0000-0002-6981-9597","observed_orcids":["https://orcid.org/0000-0002-6981-9597"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terra B. Potocky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jing Shan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Shan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018299045","display_name":"Frank J. Delfino","orcid":"https://orcid.org/0000-0002-2133-1963","observed_orcids":["https://orcid.org/0000-0002-2133-1963"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank J. Delfino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001414857","display_name":"Ergang Shi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ergang Shi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008369148","display_name":"Tammy T. Huang","orcid":"https://orcid.org/0000-0003-0127-4743","observed_orcids":["https://orcid.org/0000-0003-0127-4743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tammy Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037209746","display_name":"Joel H. Martin","orcid":"https://orcid.org/0000-0002-0507-9390","observed_orcids":["https://orcid.org/0000-0002-0507-9390"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joel H. Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100389268","display_name":"Gang Chen","orcid":"https://orcid.org/0000-0002-4864-1451","observed_orcids":["https://orcid.org/0000-0002-4864-1451","https://orcid.org/0000-0003-2402-2987","https://orcid.org/0000-0002-8105-2384"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gang Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111467970","display_name":"Douglas MacDonald","orcid":"https://orcid.org/0000-0002-3369-8754","observed_orcids":["https://orcid.org/0000-0002-3369-8754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas MacDonald","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110126197","display_name":"John S. Rudge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John S. Rudge","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015053419","display_name":"Gavin Thurston","orcid":"https://orcid.org/0000-0002-4105-5919","observed_orcids":["https://orcid.org/0000-0002-4105-5919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gavin Thurston","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5029586728","display_name":"Christopher Daly","orcid":"https://orcid.org/0000-0003-3800-8174","observed_orcids":["https://orcid.org/0000-0003-3800-8174"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Daly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.8159999847412109},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.5799999833106995},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.8939999938011169},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":1.0},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.5910000205039978},{"id":"https://openalex.org/keywords/neuregulin-1","display_name":"neuregulin-1","score":0.9580000042915344},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.7990000247955322},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.9800000190734863},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6010000109672546},{"id":"https://openalex.org/keywords/antibody-blockade","display_name":"antibody blocking","score":0.382999986410141},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7009999752044678}],"concepts":[{"id":"https://openalex.org/C115456853","wikidata":"https://www.wikidata.org/wiki/Q17917132","display_name":"ERBB3","level":4,"score":0.8780578374862671},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.7019244432449341},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6527165174484253},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.6362239718437195},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5997843742370605},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.554004430770874},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5467362403869629},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.493750661611557},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.48290276527404785},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.48213598132133484},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.480878621339798},{"id":"https://openalex.org/C2779251935","wikidata":"https://www.wikidata.org/wiki/Q5385089","display_name":"ErbB","level":3,"score":0.4599766731262207},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43417826294898987},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3754483759403229},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.32327204942703247},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2564659118652344},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.25099238753318787},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19286024570465088},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.08931222558021545}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6536475","doi":"https://doi.org/10.1158/1535-7163.c.6536475","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536475","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6536475","doi":"https://doi.org/10.1158/1535-7163.c.6536475","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536475","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2154469201","https://openalex.org/W1565257758","https://openalex.org/W2738452418","https://openalex.org/W2320340098","https://openalex.org/W2782017942","https://openalex.org/W2567525908","https://openalex.org/W4220980565","https://openalex.org/W4362488731","https://openalex.org/W2964880501","https://openalex.org/W4392688381"],"abstract_inverted_index":{"Abstract":[0],"EGFR":[1,31,56,61,76,95,171,221,241],"blocking":[2,50,136,242],"antibodies":[3,51,124],"are":[4,37,64],"approved":[5],"for":[6],"the":[7,28,33,119,122,168,187,195,211,218],"treatment":[8],"of":[9,30,75,81,89,94,101,109,116,121,127,170,189,197,210,220],"colorectal":[10,146,174,192],"cancer":[11,147,175,193],"and":[12,14,55,62,71,77,145,159,181,191],"head":[13],"neck":[15],"squamous":[16],"cell":[17,69,83,105,176],"carcinoma":[18],"(HNSCC).":[19],"Although":[20],"ERBB3":[21,53,63,78,110,141],"signaling":[22,165],"has":[23],"been":[24],"proposed":[25],"to":[26,138,166],"limit":[27],"effectiveness":[29,219],"inhibitors,":[32],"underlying":[34],"molecular":[35],"mechanisms":[36],"not":[38,157],"fully":[39],"understood.":[40],"To":[41],"gain":[42],"insight":[43],"into":[44],"these":[45,82,128],"mechanisms,":[46],"we":[47],"generated":[48],"potent":[49],"against":[52],"(REGN1400)":[54],"(REGN955).":[57],"We":[58,132],"show":[59,139],"that":[60,72,140,160,208,224],"coactivated":[65],"in":[66,103,143,229],"multiple":[67],"HNSCC":[68,104,144,190],"lines":[70,84],"combined":[73,239],"blockade":[74,88,108,172],"inhibits":[79],"growth":[80,188],"more":[85],"effectively":[86],"than":[87],"either":[90],"receptor":[91],"alone.":[92],"Blockade":[93],"with":[96,111,154,240],"REGN955":[97,182,200],"strongly":[98,113],"inhibited":[99,114],"activation":[100,115,209],"ERK":[102],"lines,":[106],"whereas":[107],"REGN1400":[112,180,198],"Akt;":[117],"only":[118],"combination":[120,196],"2":[123],"blocked":[125],"both":[126],"essential":[129],"downstream":[130],"pathways.":[131],"used":[133],"a":[134,230],"HER2":[135],"antibody":[137],"phosphorylation":[142],"cells":[148],"is":[149,227],"strictly":[150],"dependent":[151],"on":[152,173],"association":[153],"HER2,":[155],"but":[156],"EGFR,":[158],"neuregulin":[161],"1":[162],"activates":[163],"ERBB3/HER2":[164,216],"reverse":[167],"effect":[169],"growth.":[177],"Finally,":[178],"although":[179],"as":[183],"single":[184],"agents":[185],"slowed":[186],"xenografts,":[194],"plus":[199],"caused":[201],"significant":[202],"tumor":[203],"regression.":[204],"Our":[205],"results":[206],"indicate":[207],"Akt":[212],"survival":[213],"pathway":[214],"by":[215],"limits":[217],"inhibition,":[222],"suggesting":[223],"REGN1400,":[225],"which":[226],"currently":[228],"phase":[231],"I":[232],"clinical":[233],"trial,":[234],"could":[235],"provide":[236],"benefit":[237],"when":[238],"antibodies.":[243],"Mol":[244],"Cancer":[245],"Ther;":[246],"13(5);":[247],"1345\u201355.":[248],"\u00a92014":[249],"AACR.":[250]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-04-05T00:00:00"}